239 related articles for article (PubMed ID: 17409484)
61. Gender-related differences in the human subthalamic area: a local field potential study.
Marceglia S; Mrakic-Sposta S; Foffani G; Cogiamanian F; Caputo E; Egidi M; Barbieri S; Priori A
Eur J Neurosci; 2006 Dec; 24(11):3213-22. PubMed ID: 17156382
[TBL] [Abstract][Full Text] [Related]
62. Multicenter study on deep brain stimulation in Parkinson's disease: an independent assessment of reported adverse events at 4 years.
Hariz MI; Rehncrona S; Quinn NP; Speelman JD; Wensing C;
Mov Disord; 2008 Feb; 23(3):416-21. PubMed ID: 18067188
[TBL] [Abstract][Full Text] [Related]
63. Deep brain stimulation of the posterior subthalamic area in the treatment of tremor.
Blomstedt P; Fytagoridis A; Tisch S
Acta Neurochir (Wien); 2009 Jan; 151(1):31-6. PubMed ID: 19093072
[TBL] [Abstract][Full Text] [Related]
64. Multi-target strategy for Parkinsonian patients: the role of deep brain stimulation in the centromedian-parafascicularis complex.
Stefani A; Peppe A; Pierantozzi M; Galati S; Moschella V; Stanzione P; Mazzone P
Brain Res Bull; 2009 Feb; 78(2-3):113-8. PubMed ID: 18812214
[TBL] [Abstract][Full Text] [Related]
65. Acute urinary retention in two patients after subthalamic nucleus deep brain stimulation (STN-DBS) for the treatment of advanced Parkinson's disease.
Fritsche HM; Ganzer R; Schlaier J; Wieland WF; Brawanski A; Lange M
Mov Disord; 2009 Jul; 24(10):1553-4. PubMed ID: 19441136
[No Abstract] [Full Text] [Related]
66. Effects of chronic subthalamic stimulation on nonmotor fluctuations in Parkinson's disease.
Witjas T; Kaphan E; Régis J; Jouve E; Chérif AA; Péragut JC; Azulay JP
Mov Disord; 2007 Sep; 22(12):1729-34. PubMed ID: 17557355
[TBL] [Abstract][Full Text] [Related]
67. Toward a closed-loop deep brain stimulation in Parkinson's disease using local field potential in parkinsonian rat model.
Amoozegar S; Pooyan M; Roughani M
Med Hypotheses; 2019 Nov; 132():109360. PubMed ID: 31442919
[TBL] [Abstract][Full Text] [Related]
68. Gender differences in patients with Parkinson's disease treated with subthalamic deep brain stimulation.
Accolla E; Caputo E; Cogiamanian F; Tamma F; Mrakic-Sposta S; Marceglia S; Egidi M; Rampini P; Locatelli M; Priori A
Mov Disord; 2007 Jun; 22(8):1150-6. PubMed ID: 17469208
[TBL] [Abstract][Full Text] [Related]
69. Effects of DBS, premotor rTMS, and levodopa on motor function and silent period in advanced Parkinson's disease.
Bäumer T; Hidding U; Hamel W; Buhmann C; Moll CK; Gerloff C; Orth M; Siebner HR; Münchau A
Mov Disord; 2009 Apr; 24(5):672-6. PubMed ID: 19185021
[TBL] [Abstract][Full Text] [Related]
70. Differential distribution of coherence between beta-band subthalamic oscillations and forearm muscles in Parkinson's disease during isometric contraction.
Reck C; Florin E; Wojtecki L; Groiss S; Voges J; Sturm V; Schnitzler A; Timmermann L
Clin Neurophysiol; 2009 Aug; 120(8):1601-9. PubMed ID: 19564131
[TBL] [Abstract][Full Text] [Related]
71. Validity of subthalamic-cortical coherency observed in patients with Parkinson's disease.
Bock A; Kühn AA; Trahms L; Sander TH
Biomed Tech (Berl); 2013 Apr; 58(2):157-64. PubMed ID: 23446923
[TBL] [Abstract][Full Text] [Related]
72. A population level computational model of the basal ganglia that generates parkinsonian Local Field Potential activity.
Tsirogiannis GL; Tagaris GA; Sakas D; Nikita KS
Biol Cybern; 2010 Feb; 102(2):155-76. PubMed ID: 20041261
[TBL] [Abstract][Full Text] [Related]
73. Electric field and stimulating influence generated by deep brain stimulation of the subthalamic nucleus.
McIntyre CC; Mori S; Sherman DL; Thakor NV; Vitek JL
Clin Neurophysiol; 2004 Mar; 115(3):589-95. PubMed ID: 15036055
[TBL] [Abstract][Full Text] [Related]
74. Rejecting deep brain stimulation artefacts from MEG data using ICA and mutual information.
Abbasi O; Hirschmann J; Schmitz G; Schnitzler A; Butz M
J Neurosci Methods; 2016 Aug; 268():131-41. PubMed ID: 27090949
[TBL] [Abstract][Full Text] [Related]
75. Analysis of simultaneous MEG and intracranial LFP recordings during Deep Brain Stimulation: a protocol and experimental validation.
Oswal A; Jha A; Neal S; Reid A; Bradbury D; Aston P; Limousin P; Foltynie T; Zrinzo L; Brown P; Litvak V
J Neurosci Methods; 2016 Mar; 261():29-46. PubMed ID: 26698227
[TBL] [Abstract][Full Text] [Related]
76. Chronic implantation of deep brain stimulation leads in animal models of neurological disorders.
Elder CM; Hashimoto T; Zhang J; Vitek JL
J Neurosci Methods; 2005 Mar; 142(1):11-6. PubMed ID: 15652612
[TBL] [Abstract][Full Text] [Related]
77. A Method for Removal of Deep Brain Stimulation Artifact From Local Field Potentials.
Qian X; Chen Y; Feng Y; Ma B; Hao H; Li L
IEEE Trans Neural Syst Rehabil Eng; 2017 Dec; 25(12):2217-2226. PubMed ID: 28113981
[TBL] [Abstract][Full Text] [Related]
78. An external portable device for adaptive deep brain stimulation (aDBS) clinical research in advanced Parkinson's Disease.
Arlotti M; Rossi L; Rosa M; Marceglia S; Priori A
Med Eng Phys; 2016 May; 38(5):498-505. PubMed ID: 27029510
[TBL] [Abstract][Full Text] [Related]
79. Artefact-free recording of local field potentials with simultaneous stimulation for closed-loop Deep-Brain Stimulation.
Debarros J; Gaignon L; He S; Pogosyan A; Benjaber M; Denison T; Brown P; Tan H
Annu Int Conf IEEE Eng Med Biol Soc; 2020 Jul; 2020():3367-3370. PubMed ID: 33018726
[TBL] [Abstract][Full Text] [Related]
80. Local field potential recordings in a non-human primate model of Parkinsons disease using the Activa PC + S neurostimulator.
Connolly AT; Muralidharan A; Hendrix C; Johnson L; Gupta R; Stanslaski S; Denison T; Baker KB; Vitek JL; Johnson MD
J Neural Eng; 2015 Dec; 12(6):066012. PubMed ID: 26469737
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
